Literature DB >> 104310

Cocaine reinforced progressive ratio performance in the rhesus monkey.

J A Bedford, L P Bailey, M C Wilson.   

Abstract

A series of experiments were conducted to determine the effectiveness of a progressive ratio (PR) procedure in measuring the relative reinforcing efficacy of several intravenous doses of cocaine. In Experiment 1, utilizing much smaller increases in the ratio requirement than previously reported, the animals generally displayed increases in breaking point with increases in the cocaine unit dose up to 0.4 mg/kg/inj. The highest dose studied (0.8 mg/kg/inj.) engendered breaking points lower than the 0.4 mg/kg dose but higher than the remaining lower doses. Experiment 2 was conducted utilizing the same reinforcement schedule as in Experiment 1 but with liquid Tang as the reward. The results demonstrated that this procedure would function to discriminate reinforcing strength with a more traditional reward. Experiment 3 examined a more expedient procedure to see if results similar to those seen in Experiment 1 could be obtained in a shorter period of time. However, the shorter procedure engendered excessive intrasubject variability, suggesting that some intermediate level of baseline experience between the 5-7 days used in Experiment 1 and the 50 reinforced responses used in Experiment 3 would be necessary to obtain consistent breaking point-unit dose functions.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 104310     DOI: 10.1016/0091-3057(78)90214-9

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  23 in total

1.  Firing rate of nucleus accumbens neurons is dopamine-dependent and reflects the timing of cocaine-seeking behavior in rats on a progressive ratio schedule of reinforcement.

Authors:  S M Nicola; S A Deadwyler
Journal:  J Neurosci       Date:  2000-07-15       Impact factor: 6.167

2.  Progressive ratio and fixed ratio schedules of cocaine-maintained responding in baboons.

Authors:  R R Griffiths; L D Bradford; J V Brady
Journal:  Psychopharmacology (Berl)       Date:  1979-10       Impact factor: 4.530

3.  Inactivation of the central nucleus of the amygdala reduces the effect of punishment on cocaine self-administration in rats.

Authors:  YueQiang Xue; Jeffery D Steketee; WenLin Sun
Journal:  Eur J Neurosci       Date:  2012-02-06       Impact factor: 3.386

4.  Parametric analysis of cocaine self-administration under a progressive-ratio schedule in rhesus monkeys.

Authors:  J K Rowlett; B W Massey; M S Kleven; W L Woolverton
Journal:  Psychopharmacology (Berl)       Date:  1996-06       Impact factor: 4.530

5.  Self-administration of cocaine on a progressive ratio schedule in rats: dose-response relationship and effect of haloperidol pretreatment.

Authors:  D C Roberts; E A Loh; G Vickers
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

6.  Oral self-administration of sweetened nicotine solutions by rats.

Authors:  A Smith; D C Roberts
Journal:  Psychopharmacology (Berl)       Date:  1995-08       Impact factor: 4.530

7.  Self-administration of GBR 12909 on a fixed ratio and progressive ratio schedule in rats.

Authors:  D C Roberts
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

8.  Different functional domains measured by cocaine self-administration under the progressive-ratio and punishment schedules in male Wistar rats.

Authors:  Udita Datta; Mariangela Martini; WenLin Sun
Journal:  Psychopharmacology (Berl)       Date:  2017-12-06       Impact factor: 4.530

Review 9.  Animal models of drug craving.

Authors:  A Markou; F Weiss; L H Gold; S B Caine; G Schulteis; G F Koob
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

10.  Comparison of the reinforcing efficacy of cocaine and procaine in rhesus monkeys responding under a progressive-ratio schedule.

Authors:  W L Woolverton
Journal:  Psychopharmacology (Berl)       Date:  1995-08       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.